ArticleInternational journal of molecular sciences2023

Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes.

Zsolt Szekeres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.